[THE INVESTOR] Daewoong Pharmaceutical (069620) fell 2.2 percent as of 10:55 a.m., Sept. 9, falling to 75,400 won (US$ 68.54). It has declined 17.51 percent over the past month. Standard deviation, which indicates risk, for the same period is 2.8 percent.

Due to monthly volatility of Daewoong Pharmaceutical being highest among competitors listed on KOSPI, the investment return for one month was negative. Over the recent month, return-on-risk was -6.2 percent.

- Compared with industrial index, the Return comparison Volatility was rather negative - Most of related stocks also decline. Medical Supplies industry -1.82% - Target price 107,100 won is 42 percent higher than the current price - Institutions and Foreigners sell, Individuals buy - Price Range is too low - Institution 18.16%, Foreigners 21.67%

Institutions have been selling for the past three trading days and foreigners have been selling for the past nine trading days. Over the past four weeks, foreigners have sold 259,847, while institutions have sold 312,002. However, during the same period, individuals have bought 571,849 shares with an increasing position.

Cumulated shareholdings per investor group (1Mo)		Total shareholdings per investor group

By HeRo (hero@heraldcorp.com)

This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.